NEW YORK (AVAFIN) -- Options traders were heavily trading call contracts during the last trading session establishing a
new 3-month call volume record. A total of 5,210 put and 16,895 calls were traded where call
contracts outnumbered puts 3.2:1, yielding a 0.31 ratio.
View Options Trading Activities
Investors use options to manage risk and to speculate on price changes. Options can provide
significant leverage if the stock moves in the right direction but aslo end up worthless if it
doesn't.
Governments in developed countries are increasingly pressing for pricing cuts in health care, creating a headwind across most of J&J's key products.
Additionaly, The 2011 patent losses on anti-infective Levaquin and neurology drug Concerta will create a drag on earnings growth through 2012.
Johnson & Johnson opened at $66.12 and the stock price declined $0.33 (0.50%)
to $65.88 during the market session. JNJ is trading between the range of
$65.50 - $66.16. To date, the stock has gained 1.49% within the last month.
Volume is 9M in relation to the three month
average volume of 9M shares. JNJ is trading above the 50
day moving average and higher than the 200 day moving average.
View Best Performing Stocks
